Occudo Quantitative Strategies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,795
Closed -$7.97M 760
2025
Q4
$7.97M Buy
38,795
+29,892
+336% +$5.63M 0.53% 49
2025
Q3
$1.4M Sell
8,903
-17,832
-67% -$2.75M 0.17% 166
2025
Q2
$4.49M Buy
26,735
+24,254
+978% +$3.6M 0.5% 53
2025
Q1
$339K Buy
+2,481
New +$316K 0.05% 450
2024
Q3
Sell
-8,853
Closed -$870K 729
2024
Q2
$870K Buy
+8,853
New +$902K 0.15% 188
2023
Q1
Sell
-12,697
Closed -$976K 923
2022
Q4
$976K Buy
+12,697
New +$965K 0.11% 295
2022
Q1
Sell
-53,786
Closed -$2.77M 1142
2021
Q4
$2.77M Sell
53,786
-4,172
-7% -$205K 0.25% 100
2021
Q3
$2.87M Sell
57,958
-3,104
-5% -$168K 0.34% 44
2021
Q2
$3.49M Buy
61,062
+55,693
+1,037% +$3.25M 0.53% 8
2021
Q1
$326K Sell
5,369
-6,066
-53% -$335K 0.07% 464
2020
Q4
$612K Buy
+11,435
New +$593K 0.19% 175

Other funds holding CAH

Occudo Quantitative Strategies's CAH Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 38,795 shares — an estimated $7.97M sold.

Occudo Quantitative Strategies first reported a position in CAH in Q4 2020 and held it in 11 quarters. The position peaked at $7.97M in Q4 2025. 1,433 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 38,795 Cardinal Health shares in Q1 2026, an estimated $7.97M.
  • Occudo Quantitative Strategies first reported a position in Cardinal Health in Q4 2020 and held it in 11 quarters.
  • Occudo Quantitative Strategies's Cardinal Health position peaked at $7.97M in Q4 2025.
  • 1,433 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.